Aggregation and fibrillation of bovine serum albumin

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 9, 2007, Pages 1128-1138

  Holm, Nikolaj K ^a   Jespersen, Stine K ^a   Thomassen, Lise V ^a   Wolff, Tine Y ^a   Sehgal, Pankaj ^a   Thomsen, Line A ^a   Christiansen, Gunna ^b   Andersen, Christian Beyschau ^c   Knudsen, Anders D ^a   Otzen, Daniel E ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Aggregation; Albumin; Amyloid; Fibrillation; Nucleation; Proteolysis

Indexed keywords

AMYLOID; BOVINE SERUM ALBUMIN; CONGO RED; PROTEINASE; THIOFLAVINE; TRIFLUOROETHANOL;

ALPHA HELIX; ARTICLE; BETA SHEET; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FIBER; HUMAN; HUMAN CELL; MICROMORPHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; X RAY DIFFRACTION;

AMYLOID; ANIMALS; CATTLE; CELL SURVIVAL; CONGO RED; NEUROBLASTOMA; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES; TRYPSIN; TUMOR CELLS, CULTURED; X-RAY DIFFRACTION;

BOVINAE;

EID: 34548210324     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.06.008     Document Type: Article

References (55)

1. Frokjaer S., and Otzen D.E. Protein drug stability-A formulation challenge. Nat. Rev., Drug. Delivery 4 (2005) 298-306
2. Dobson C.M. Protein folding and misfolding. Nature 426 (2003) 884-890
3. Khurana R., Ionescu-Zanetti C., Pope M., Li J., Nielson L., Ramirez-Alvarado M., Regan L., Fink A.L., and Carter S.A. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys. J. 85 (2003) 1135-1144
4. Chiti F., Stefani M., Taddei N., Ramponi G., and Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
5. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
6. Hortscansky P., Christopeit T., Schroeckh V., and Fändrich M. Thermodynamic analysis of the aggregation propensity of oxidized Alzheimer's beta-amyloid variants. Protein Sci. 14 (2005) 2915-2918
7. Pedersen J.S., Christiansen G., and Otzen D.E. Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. J. Mol. Biol. 341 (2004) 575-588
8. Fändrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
9. Fändrich M., Forge V., Buder K., Kittler M., Dobson C.M., and Diekmann S. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15463-15468
10. Volles M.J., and Lansbury P.T. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42 (2003) 7871-7878
11. Volles M.J., Lee S.-J., Rochet J.-C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury P.T. Vesicle permeabilization by protofibrillar a-synuclein: Implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
12. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., and Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279 (2004) 46363-46366
13. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
14. Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C.M., and Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279 (2004) 31374-31382
15. Pepys M.B., Hawkins P.H., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Bguyen O., Blake C.C., Terry C.J., Feest T.G., Zalin A.M., and Hsuan J.J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362 (1993) 553-557
16. Gebbink M.F.B.G., Claessen D., Bouma B., Dijkhuizen L., and Wösten H.A.B. Amyloids-A functional coat for microorganisms. Nat. Rev. Microbiol. 3 (2005) 333-341
17. Harper J.D., and Lansbury P.T.J. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
18. Ferrone F. Analysis of protein aggregation kinetics. Methods Enzymol. 309 (1999) 256-274
19. Chiti F., Taddei N., Baroni F., Capanni C., Stefani M., Ramponi G., and Dobson C.M. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9 (2002) 137-143
20. Calamai M., Canale C., Relini A., Stefani M., Chiti F., and Dobson C.M. Reversal of protein aggregation provides evidence for multiple aggregated states. J. Mol. Biol. 346 (2005) 603-616
21. Sugio S., Kashima A., Mochizuki S., Noda M., and Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12 (1999) 439-446
22. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 37 (1990) 57-84
23. Millitello V., Verti V., and Leone M. Conformational changes involved in thermal aggregation processes of bovine serum albumin. Biophys. Chem. 105 (2003) 133-141
24. Vaiana S.M., Emanuele A., Palma-Vittorelli M.B., and Palma M.U. Irreversible formation of intermediate BSA oligomers requires and induces conformational changes. Proteins 55 (2004) 1053-1062
25. Murayama K., and Tomida M. Heat-induced secondary structure and conformation change of bovine serum albumin investigated by Fourier Transform Infrared Spectroscopy. Biochemistry 2004 (2004) 11526-11532
26. Wimmer R., Andersen K., Davidsen M., Mølgaard S., Vad B., and Otzen D.E. Versatile interactions of the antimicrobial peptide Novispirin with detergents and lipids. Biochemistry 45 (2006) 481-497
27. Zuidam N.J., de Vrueh R., and Crommelin D.J.A. Characterization of liposomes. In: Torchilin V.P., and Weissig V. (Eds). Liposomes A Practical Approach (2003), Oxford Univ. Press, Oxford 31-78
28. Klunk W.E., Jacob R.F., and Mason R.P. Quantifying amyloid by Congo Red spectral shift assay. Methods Enzymol. 309 (1999) 285-305
29. Mogensen J.E., Ibsen H., Lund J., and Otzen D.E. Elimination of an off-pathway folding intermediate by a single point mutation. Biochemistry 43 (2004) 3357-3367
30. Klemm P., and Christiansen G. Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 208 (1987) 439-445
31. Yang J.J., Yang H., Ye Y., Hopkins J., and Hastings G. Temperature-induced formation of a non-native intermediate state of the all β-sheet protein CD2. Cell Biochem. Biophys. 36 (2002) 1-18
32. Makin O.S., and Serpell L.C. X-ray diffraction studies of amyloid structure. Methods Mol. Biol. 299 (2005) 67-80
33. Frare E., Mossuto M.F., De Laureto P.P., Dumoulin M., Dobson C.M., and Fontana A. Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J. Mol. Biol. 3651 (2006) 551-561
34. Chiti F., Taddei N., Bucciantini M., White P., Ramponi G., and Dobson C.M. Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J. 19 (2000) 1441-1449
35. Otzen D.E., Sehgal P., and Nesgaard L. Alternative membrane protein conformations in alcohols. Biochemistry 46 (2007) 4348-4359
36. Liu Y., Peterson D.A., Kimura H., and Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69 (1997) 581-593
37. Kremer J.J., Sklansky D.J., and Murphy R.M. Profile of changes in lipid bilayer structure caused by b-amyloid peptide. Biochemistry 40 (2001) 8563-8571
38. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and Lal R. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10427-10432
39. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., and Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 3590-3594
40. Dobson C.M. Protein misfolding, evolution and disease. TIBS 24 (1999) 329-332
41. Kheterpal I., Williams A.D., Murphy C., Bledsoe B., and Wetzel R. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. Biochemistry 40 (2001) 11757-11767
42. Bousset L., Redeker V., Decottignies P., Dubois S., Le Marechal P., and Melki R. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p. Biochemistry 43 (2004) 5022-5032
43. Monti M., Amoresano A., Giorgetti S., Bellotti V., and Pucci P. Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states. Biochim Biophys. Acta 1753 (2005) 44-50
44. Hong D.-P., Gozu M., Hasegawa K., Naiki H., and Goto Y. Conformation of beta2-microglobulin amyloid fibrils analyzed by reduction of the disulfide bond. J. Biol. Chem. 277 (2002) 21554-21560
45. Radford S.E., Gosal W.S., and Platt G.W. Towards an understanding of the structural molecular mechanism of beta2-microglobulin amyloid formation in vitro. Biochim Biophys. Acta 1753 (2005) 51-63
46. Otzen D.E., and Oliveberg M. Transient formation of nanocrystalline structures during fibrillation of an Alzheimer-like peptide. Protein Sci. 13 (2004) 1417-1421
47. Grudzielanek S., Smirnovas V., and Winter R. Solvation-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications. J. Mol. Biol. 356 (2006) 497-509
48. Wright C.F., Teichmann S.A., Clarke J., and Dobson C.M. The importance of sequence diversity in the aggregation and evolution of proteins. Nature 438 (2005) 881
49. Sambashivan S., Liu Y., Sawaya M.R., Gingery M., and Eisenberg D. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437 (2005) 266-269
50. Ranson N., Stromer T., Bousset L., Melki R., and Serpell L.C. Insights into the architecture of the Ure2p yeast protein assemblies from helical twisted fibrils. Protein Sci. 15 (2006) 2481-2487
51. Heise H., Hoyer W., Becker S., Andronesi O.C., Riedel D., and Baldus M. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15871-15876
52. Pedersen J.S., Dikov D., Flink J.L., and Otzen D.E. Sulfates dramatically stabilize a salt dependent type of glucagon fibrils. Biophys. J. 90 (2006) 4181-4194
53. Pedersen J.S., Dikov D., Flink J.L., Hjuler H.A., Christiansen G., and Otzen D.E. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol. 355 (2006) 501-523
54. Tanaka M., Chien P., Naber N., Cooke R., and Weissman J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428 (2004) 323-328
55. Petkova A.T., Leapman R.D., Guo Z., Yau W.-M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's b-amyloid fibrils. Science 307 (2005) 262-265